Rationale and results of correction of cognitive dysfunction in patients with chronic heart failure and a reduced left ventricular ejection fraction using a combination of meldonium and gamma-butyrobetaine
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4
Abstract
The aim — to evaluate the effect of the innovative combination of meltedonium and γ‑butyrobetaine (GBB) on the state of cognitive function, quality of life and endothelial function in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LV EF). Materials and methods. We examined 24 patients with stable CHF and reduced LV EF (< 40 %) of the II — III functional class according to NYHA not older than 75 years who had cognitive impairments identified using standardized testing. All patients underwent general clinical examination using standard methods of psychological testing (Mini‑Mental State Examination (MMSE), Schulte tests, HADS scale, Minnesota Living with Heart Failure Questionnaire (MLHFQ), self‑assessment by patients of household physical activity using the Duke University questionnaire), ultrasound diagnosis of the vasodilating function of the endothelium of the brachial artery (VDFE BA) using a test with reactive hyperemia. The combination of meldonium with GBB was administered in a dose of 2 capsules three times a day (every 8 hours) for 4 weeks. Results and discussion. After treatment with a combination of meldonium and GBB, we observed a statistically significant improvement in cognitive function indicators on the MMSE scale (p < 0.001), Schulte test (p < 0.001), as well as the quality of life by MLHFQ (p = 0.02). While taking the drug, a significant improvement of the endothelium‑dependent vasodilatory response was observed (p < 0.001). No statistically significant effect of the combination of meldonium and GBB on the level of anxiety (HADS‑A scale) and depression (HADS‑D) was observed. Conclusions. Administration to patients with CHF and decreased LV EF of a fixed combination of meldonium and GBB for 4 weeks in addition to standard basic treatment (angiotensin‑converting enzyme inhibitor, b‑blocker, mineralcorticoid receptor antagonist, diuretic) was associated with a statistically significant improvement in cognitive tests results (total score by MMSE, Schulte test run time), quality of life by MLHFQ and significant improvement in VDFE BA according to the test with reactive hyperemia.
Authors and Affiliations
L. G. Voronkov, A. S. Solonovych, A. V. Liashenko
Keywords
Related Articles
- EP ID EP451277
- DOI 10.30978/HV2018-4-62
- Views 136
- Downloads 0
Changes of indices of diurnal blood pressure monitoring under the influence of treatment in patients with essential hypertension complicated with hemorrhagic stroke after early recovery period
The aim — to compare the indices of diurnal blood pressure monitoring (DBPM) in patients with essential hypertension (EH) іn ≥ 6 months after hemorrhagic stroke (HS) before and after treatment with combination of amlodi...
Risk of heart rhythm disorders in patients with chronic obstructive pulmonary disease, combined with ischemic heart disease during computer spirography
The aim — to evaluate the safety of spirography with bronchodilation test in patients with a combination of stable ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD). Materials and methods. 14...
Relationship between indicators of pulse wave and bone mineral density in elderly aged women with uncomplicated hypertension
The aim — to perform a comparative analysis of the indices of central aortic pressure and pulse wave, bone mineral density (BMD) in elderly female patients with uncomplicated essential hypertension. Materials and method...
Preoperative planning of on-pump beating-heart coronary artery bypass grafting based on prediction of intraoperative complications
The aim — to improve the results of coronary artery bypass grafting in patients with ischemic heart disease by determining indications for direct myocardial revascularization on a beatingheart in conditions of parallel...
Clinical and anamnestic characteristics of patients with acute pulmonary embolism
The aim — to analyze the features of the course and the main factors of development of pulmonary embolism (PE). Materials and methods. During the period from January 1, 2014 until July 1, 2018, 774 patients with acute p...